Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Schuhmacher

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Discovery|October 15, 2024
Exploring open source as a strategy to enhance R&D productivityAlexander Schuhmacher
Drug Discovery Today|November 7, 2024
Pharma innovation: how evolutionary economics is shaping the future of pharma R&DAlexander Schuhmacher
Expert Opinion on Drug Discovery|April 8, 2020
The impact of crowdsourcing in modern drug discoveryAlexander Schuhmacher, Michael Kuss
Journal of Translational Medicine|April 28, 2016
Changing R&D models in research-based pharmaceutical companiesAlexander Schuhmacher, Oliver Gassmann, Markus Hinder
Drug Discovery Today|July 20, 2019
The Art of Virtualizing Pharma R&DAlexander Schuhmacher, Oliver Gassmann, Michael Kuss, et al.
Drug Discovery Today|August 4, 2020
The present and future of project management in pharmaceutical R&DAlexander Schuhmacher, Oliver Gassmann, Markus Hinder, et al.
Journal of Translational Medicine|May 10, 2018
Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?Alexander Schuhmacher, Oliver Gassmann, Nigel McCracken, et al.
Drug Discovery Today|August 3, 2024
Comparative analysis of FDA approvals by top 20 pharma companies (2014-2023)Alexander Schuhmacher, Oliver Gassmann, Markus Hinder, et al.
Drug Discovery Today|September 20, 2025
The Role of Data Monitoring Committees in drug researchMarkus Hinder, Nandhini Madesh, Dominik Hartl, et al.
Drug Discovery Today|July 30, 2013
Models for open innovation in the pharmaceutical industryAlexander Schuhmacher, Paul-Georg Germann, Henning Trill, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Discovery|October 15, 2024
Exploring open source as a strategy to enhance R&D productivityAlexander Schuhmacher
Drug Discovery Today|November 7, 2024
Pharma innovation: how evolutionary economics is shaping the future of pharma R&DAlexander Schuhmacher
Expert Opinion on Drug Discovery|April 8, 2020
The impact of crowdsourcing in modern drug discoveryAlexander Schuhmacher, Michael Kuss
Journal of Translational Medicine|April 28, 2016
Changing R&D models in research-based pharmaceutical companiesAlexander Schuhmacher, Oliver Gassmann, Markus Hinder
Drug Discovery Today|July 20, 2019
The Art of Virtualizing Pharma R&DAlexander Schuhmacher, Oliver Gassmann, Michael Kuss, et al.
Drug Discovery Today|August 4, 2020
The present and future of project management in pharmaceutical R&DAlexander Schuhmacher, Oliver Gassmann, Markus Hinder, et al.
Journal of Translational Medicine|May 10, 2018
Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?Alexander Schuhmacher, Oliver Gassmann, Nigel McCracken, et al.
Drug Discovery Today|August 3, 2024
Comparative analysis of FDA approvals by top 20 pharma companies (2014-2023)Alexander Schuhmacher, Oliver Gassmann, Markus Hinder, et al.
Drug Discovery Today|September 20, 2025
The Role of Data Monitoring Committees in drug researchMarkus Hinder, Nandhini Madesh, Dominik Hartl, et al.
Drug Discovery Today|July 30, 2013
Models for open innovation in the pharmaceutical industryAlexander Schuhmacher, Paul-Georg Germann, Henning Trill, et al.
Pageof 3